Defendants. )

Preview:

Citation preview

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF TENNESSEE

UNITED STATES OF AMERICA, ) )

���� ) )

Civil Action No. -----

V. ) )

KEYSTONE LABORATORIES, INC., a corporation,)

CONSENT DECREE OF PERMANENT INJUNCTION

MELINDA MENKE and ELIZABETH JUMET, ) individuals, )

) Defendants. )

_________________ )

Plaintiff, the United States of America, by and through its undersigned attorneys, having

filed a Complaint for Permanent Injunction against Keystone Laboratories, Inc., a corporation,

and Melinda Menke and Elizabeth Jumet, individuals (hereinafter, collectively, "Defendants"),

and Defendants having appeared and consented to entry of this Decree without contest, and

before any testimony has been taken, and the United States of America, having consented to this

Decree;

IT IS HEREBY ORDERED, ADJUDGED, AND DECREED as follows:

1. This Court has jurisdiction over the subject matter of this action and all parties to this

action. Venue is proper in this District under 28 U.S.C. § 1391(b) and (c).

2. The Complaint states a cause of action against Defendants under the Federal

Food, Drug, and Cosmetic Act, 21 U.S.C. §§ 301 et seq. (the "Act").

3. The Complaint alleges that Defendants violate 21 U.S.C. § 33 l(a) by introducing or

delivering for introduction, or causing to be introduced or delivered for introduction, into

interstate commerce articles of drug, as defined by 21 U.S.C. § 321(g)(l), that are adulterated

18-2656

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 1 of 26 PageID 20

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 2 of 26 PageID 21

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 3 of 26 PageID 22

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 4 of 26 PageID 23

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 5 of 26 PageID 24

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 6 of 26 PageID 25

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 7 of 26 PageID 26

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 8 of 26 PageID 27

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 9 of 26 PageID 28

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 10 of 26 PageID 29

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 11 of 26 PageID 30

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 12 of 26 PageID 31

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 13 of 26 PageID 32

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 14 of 26 PageID 33

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 15 of 26 PageID 34

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 16 of 26 PageID 35

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 17 of 26 PageID 36

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 18 of 26 PageID 37

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 19 of 26 PageID 38

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 20 of 26 PageID 39

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 21 of 26 PageID 40

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 22 of 26 PageID 41

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 23 of 26 PageID 42

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 24 of 26 PageID 43

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 25 of 26 PageID 44

Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 26 of 26 PageID 45

Recommended